Fred Hassan is currently Chairman of the Board and Chief Executive Officer of the pharmaceutical company Schering-Plough since April 2003. The company spends over $300,000 on security to protect Hassan, who has received death threats from animal rights groups[1].
Education
Hassan was trained as a chemical engineer by the Imperial College London where he received a BS degree. In addition he has a MBA degree from Harvard Business School.
Business Career
Hassan began his career with Sandoz Pharmaceuticals, where he spent 17 years and ended up leading its U.S. pharmaceuticals business. He then became executive vice president of Wyeth, responsibile for its pharmaceutical and medical products divisions, and was elected to the Board of Directors in 1995. Hassan joined Pharmacia & Upjohn in May 1997 as chief executive officer and in February 2001 he was named Chairman of the Board of Pharmacia after the merger with Monsanto. He has also served as Chairman of the Board of Directors for the Pharmaceutical Research and Manufacturers of America (PhRMA) and for the HealthCare Institute of New Jersey. Hassan is also the current president of the International Federation of Pharmaceutical Manufacturers Associations and serves on the Board of Directors of Avon Products, Inc.
References
 | This article about a United States businessperson is a stub. You can help Wikipedia by expanding it. |